Literature DB >> 27311601

Postoperative appointments: which ones count?

Margaret G Mueller1,2, Dana Elborno3, Bhumy A Davé4, Alix Leader-Cramer4, Christina Lewicky-Gaupp4, Kimberly Kenton4.   

Abstract

INTRODUCTION AND HYPOTHESIS: Although postoperative complications in women undergoing reconstructive pelvic surgery (RPS) have been characterized, little is known regarding the timeline of these occurrences. We aimed to determine the timeframe after RPS during which the majority of complications occur, to assist with planning intervals between postoperative visits.
METHODS: Women undergoing RPS were identified through billing information. Demographic, surgical, and complications data were extracted from electronic medical records. The Pelvic Floor Complication scale is a surgical scale tailored to women undergoing RPS. It contains three subscales: intraoperative, immediately postoperative, and delayed complications. We applied this scale to each postoperative visit (at 2, 6, and 13 weeks).
RESULTS: 396 women underwent RPS and 125 patients had 179 complications, most of which (66 %) were identified by the 2-week visit. Complications at the 2-week visit consisted of urinary tract infection (UTI; 46 %), wound infection (10.0 %), and urinary retention (9.4 %). The majority of serious complications (venous thromboembolism [VTE], ileus, small bowel obstruction [SBO], readmission, and reoperation [1 incarcerated hernia and 1 sling release]) were diagnosed by 2 weeks. One patient was readmitted for ileus at between 2 and 6 weeks. At between 6 and 13 weeks, 1 patient was readmitted with SBO; 1 VTE was diagnosed; and 1 required reoperation for a prolapsed fallopian tube. In contrast, two thirds of the complications seen at the 13-week visit were due to granulation tissue, suture erosion or mesh erosion.
CONCLUSIONS: The majority of non-mesh-related complications occur within the first 2 weeks after RPS, whereas mesh and suture complications are more likely to be identified at the 13-week visit.

Entities:  

Keywords:  Pelvic floor disorders; Postoperative complications; Reconstructive pelvic surgery; Urogynecology

Mesh:

Year:  2016        PMID: 27311601     DOI: 10.1007/s00192-016-3052-2

Source DB:  PubMed          Journal:  Int Urogynecol J        ISSN: 0937-3462            Impact factor:   2.894


  20 in total

1.  Symptomatic urinary tract infections after surgery for prolapse and/or incontinence.

Authors:  Gary Sutkin; Marianna Alperin; Leslie Meyn; Harold C Wiesenfeld; Rennique Ellison; Halina M Zyczynski
Journal:  Int Urogynecol J       Date:  2010-03-31       Impact factor: 2.894

2.  ACOG Practice Bulletin No. 84: Prevention of deep vein thrombosis and pulmonary embolism.

Authors: 
Journal:  Obstet Gynecol       Date:  2007-08       Impact factor: 7.661

3.  ACOG practice bulletin No. 104: antibiotic prophylaxis for gynecologic procedures.

Authors: 
Journal:  Obstet Gynecol       Date:  2009-05       Impact factor: 7.661

4.  Comparison of 2 transvaginal surgical approaches and perioperative behavioral therapy for apical vaginal prolapse: the OPTIMAL randomized trial.

Authors:  Matthew D Barber; Linda Brubaker; Kathryn L Burgio; Holly E Richter; Ingrid Nygaard; Alison C Weidner; Shawn A Menefee; Emily S Lukacz; Peggy Norton; Joseph Schaffer; John N Nguyen; Diane Borello-France; Patricia S Goode; Sharon Jakus-Waldman; Cathie Spino; Lauren Klein Warren; Marie G Gantz; Susan F Meikle
Journal:  JAMA       Date:  2014-03-12       Impact factor: 56.272

5.  Cost differences among robotic, vaginal, and abdominal hysterectomy.

Authors:  Joshua L Woelk; Bijan J Borah; Emanuel C Trabuco; Herbert C Heien; John B Gebhart
Journal:  Obstet Gynecol       Date:  2014-02       Impact factor: 7.661

6.  A midurethral sling to reduce incontinence after vaginal prolapse repair.

Authors:  John T Wei; Ingrid Nygaard; Holly E Richter; Charles W Nager; Matthew D Barber; Kim Kenton; Cindy L Amundsen; Joseph Schaffer; Susan F Meikle; Cathie Spino
Journal:  N Engl J Med       Date:  2012-06-21       Impact factor: 91.245

7.  Risk of deep venous thrombosis and pulmonary embolism in urogynecologic surgical patients.

Authors:  Ellen R Solomon; Anna C Frick; Marie Fidela R Paraiso; Matthew D Barber
Journal:  Am J Obstet Gynecol       Date:  2010-08-30       Impact factor: 8.661

8.  Satisfaction in patients undergoing concurrent pelvic floor surgery for stress urinary incontinence and pelvic organ prolapse.

Authors:  Jeff P Wolters; Ashley B King; David E Rapp
Journal:  Female Pelvic Med Reconstr Surg       Date:  2014 Jan-Feb       Impact factor: 2.091

9.  Patient-centered surgical outcomes: the impact of goal achievement and urge incontinence on patient satisfaction one year after surgery.

Authors:  Sangeeta T Mahajan; Eman A Elkadry; Kimberly S Kenton; Susan Shott; Linda Brubaker
Journal:  Am J Obstet Gynecol       Date:  2006-03       Impact factor: 8.661

10.  The pelvic floor complication scale: a new instrument for reconstructive pelvic surgery.

Authors:  Robert E Gutman; Ingrid E Nygaard; Wen Ye; David D Rahn; Matthew D Barber; Halina M Zyczynski; Leslie Rickey; Charles W Nager; R Edward Varner; Kimberly Kenton; Kimberly J Dandreo; Holly E Richter
Journal:  Am J Obstet Gynecol       Date:  2012-11-03       Impact factor: 8.661

View more
  3 in total

1.  Outpatient visits versus telephone interviews for postoperative care: a randomized controlled trial.

Authors:  Jennifer C Thompson; Sara B Cichowski; Rebecca G Rogers; Fares Qeadan; Julissa Zambrano; Cynthia Wenzl; Peter C Jeppson; Gena C Dunivan; Yuko M Komesu
Journal:  Int Urogynecol J       Date:  2019-02-19       Impact factor: 2.894

2.  Surgical approach and unplanned readmission following pelvic organ prolapse surgery: a retrospective cohort study using data from the National Surgical Quality Improvement Program Database (NSQIP).

Authors:  Aisling A Clancy; Innie Chen; Dante Pascali; Vatche A Minassian
Journal:  Int Urogynecol J       Date:  2020-08-25       Impact factor: 2.894

3.  Telemedicine follow-up is safe and efficacious for synthetic midurethral slings: a randomized, multi-institutional control trial.

Authors:  Laura L Giusto; Samir Derisavifard; Patricia M Zahner; Jessica J Rueb; Luo Deyi; Li Jiayi; Fang Weilin; Raphael de Jesus Moreira; Alexander Gomelsky; Matteo Balzarro; Howard B Goldman
Journal:  Int Urogynecol J       Date:  2021-04-20       Impact factor: 1.932

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.